Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Transgenomic Inc

+ Add to Watchlist

TBIO:US

1.7800 USD 0.0400 2.30%

As of 17:20:00 ET on 03/02/2015.

Snapshot for Transgenomic Inc (TBIO)

Open: 1.8000 Day's Range: 1.7500 - 1.8500 Volume: 149,308
Previous Close: 1.7400 52wk Range: 1.4100 - 5.9000 1-Yr Rtn: -65.44%

Stock Chart for TBIO

No chart data available.
  • TBIO:US 1.7800
  • 1D
  • 1M
  • 1Y
1.7400
Interactive TBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TBIO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.6300
Est. EPS (USD) (12/2014) -1.9000
Est. PEG Ratio -
Market Cap (M USD) 21.11
Shares Outstanding (M) 11.86
30 Day Average Volume 136,723
Price/Book (mrq) 1.2842
Price/Sale (ttm) 0.6576
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TBIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TBIO

Transgenomic, Inc. provides research tools to the life sciences industry. These tools enable researchers to discover and understand variation in the human genetic code, or genome, in order to accelerate and improve drug development and diagnostics.

Paul KinnonPresident/CEO/Interim CFO/SecyLeon RichardsChief Acctg Officer/Controller
More Company Profile & Key Executives for TBIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil